Thrombopoietin: Understanding and manipulating platelet production

Annual Review of Medicine

Volumn 48, Issue , 1997, Pages 1-11

  Kaushansky, K ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Hematopoiesis; Megakaryocytes; Mp1 ligand; Platelet production; Thrombopoiesis

Indexed keywords

CYTOKINE; HORMONE; RECEPTOR; THROMBOPOIETIN;

BLOOD CELL; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; ERYTHROCYTE; ERYTHROID CELL; HEMATOPOIETIC STEM CELL; LEUKOCYTE; MEGAKARYOCYTE; MOLECULAR CLONING; PRIORITY JOURNAL; REVIEW; STEM CELL; THROMBOCYTOPOIESIS;

ANIMALS; BLOOD PLATELETS; CELL DIFFERENTIATION; CYTOKINES; HEMATOPOIETIC STEM CELLS; HUMANS; MEGAKARYOCYTES; NEOPLASM PROTEINS; PLATELET COUNT; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; RECOMBINANT PROTEINS; THROMBOPOIETIN;

EID: 0031051965     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.48.1.1     Document Type: Review

References (82)

1. de Sauvage FJ, Hass PE, Spencer SD, et al. 1994. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533-38
2. Lok S, Kaushansky K, Holly R, et al. 1994. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565-68
3. Bartley TD, Bogenberger J, Hunt P, et al. 1994. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117-24
4. Sohma Y, Akahori H, Seki N, et al. 1994. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett. 353:57-61
5. Kuter DJ, Beeler DL, Rosenberg RD. 1994. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc. Natl. Acad. Sci. USA 91:11104-8
6. McDonald TP. 1988. Thrombopoietin: its biology, purification, and characterization. Exp. Hematol. 16:201-5
7. Hill RJ, Levin J. 1989. Regulators of thrombopoiesis: their biochemistry and physiology. Blood Cells 15:141-66
8. Pluznik DH, Sachs L. 1965. The cloning of normal mast cells in tissue culture. J. Cell. Physiol. 66:319-24
9. Bradley TR, Metcalf D. 1966. The growth of mouse bone marrow cells in vitro. Aust. J. Exp. Biol. Med. Sci. 44:287-99
10. Metcalf D. 1993. Hematopoietic regulators: redundancy or subtlety? Blood 82: 3515-23
11. Ogawa M. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844-53
12. Messner HA, Fauser AA, Lepine J, et al. 1980. Properties of human pluripotent hemopoietic progenitors. Blood Cells 6: 595-607
13. Ash RC, Detrick DA, Zanjani ED. 1981. Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitro. Blood 58:309-16
14. Dai CH, Krantz SB, Zsebo KM. 1991. Human burst forming units-erythroid need direct interaction with stem cell factor for further development. Blood 78: 2493-97
15. Muta K, Krantz SB, Bondurant MC, et al. 1994. Distinct roles of erythropoietin, insulin like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J. Clin. Invest. 94:34-43
16. Russell ES. 1979. Hereditary anemias of the mouse: a review for geneticists. Adv. Genet. 20:357-459
17. Witte ON. 1990. Steel locus defines new multipotent growth factor. Cell 63:5-6
18. Flanagan JG, Chan DC, Leder P. 1991. Transmembrane form of the kit ligand growth factor is determined by alternate splicing and is missing in the Sld mutant. Cell 64:1025-35
19. Dessypris EN, Graber SE, Krantz SB, et al. 1988. Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood 72:2060-62
20. Broxmeyer HE, Williams DE, Hangoc G, et al. 1987. Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3 and recombinant murine granulocyte/macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 84:3871-75
21. Bot FJ, van Ejik L, Schipper P, et al. 1989. Effects of human interleukin-3 on granulocytic colony-forming cells in human bone marrow. Blood 73:1157-60
22. Brandt JE, Bhalla K, Hoffman R. 1994. Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. Blood 83: 1507-14
23. McNiece I, Andrews R, Stewart M, et al. 1989. Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF. Blood 74:110-14
24. Paul CC, Tolbert M, Mahrer S, et al. 1993. Cooperative effects of interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor: a new myeloid cell line inducible to eosinophils. Blood 81:1193-99
25. Williams N, Jackson H. 1982. Kinetic analysis of megakaryocyte numbers and ploidy levels in developing colonies from mouse bone marrow cells. Cell Tissue Kinet. 15:483-94
26. Long MW, Gragowski LL, Heffner CH, et al. 1985. Phorbol diesters stimulate the development of an early murine progenitor cell: the burst-forming unit-megakaryocyte. J. Clin. Invest. 76:431-38
27. Briddell RA, Hoffman R. 1990. Cytokine regulation of the human burst-forming unit-megakaryocyte. Blood 76:516-22
28. Williams N, Eger RR, Jackson HM, et al. 1982. Two-factor requirement for murine megakaryocyte colony formation. J. Cell. Physiol. 110:101-4
29. Williams N, Jackson H, Walker F, et al. 1989. Multiple levels of regulation of megakaryocytopoiesis. Blood Cells 15: 123-33
30. Segal GM, Stueve T, Adamson JW. 1988. Analysis of murine megakaryocyte colony size and ploidy: effects of interleukin-3. J. Cell. Physiol. 137:537-44
31. Debili N, Massé J-M, Katz A, et al. 1993. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells. Blood 82:84-95
32. Avraham H, Vannier E, Cowley S, et al. 1992. Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood 79:365-71
33. Briddell RA, Bruno E, Cooper RJ, et al. 1991. Effect of c-kit ligand on in vitro human megakaryocytopoiesis. Blood 78: 2854-59
34. Kaushansky K, O'Hara RJ, Berkner K, et al. 1986. Genomic cloning, characterization and multilineage growth-promoting activity of human granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 83:3101-5
35. Kelemen E, Cserhati I, Tanos B. 1958. Demonstration and some properties of human thrombopoietin in thrombocythemic sera. Acta Haematol. 20:350-55
36. Quesenberry PJ, McGrath HE, Williams ME, et al. 1991. Multifactor stimulation of megakaryocytopoiesis: effects of interleukin-6. Exp. Hematol. 19:35-41
37. Kimura H, Ishibashi T, Uchida T, et al. 1990. Interleukin 6 is a differentiation factor for human megakaryocytes in vitro. Eur. J. Immunol. 20:1927-31
38. Paul SR, Bennett F, Calvetti JA, et al. 1990. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl. Acad. Sci. USA 87:7512-16
39. Yonemura Y, Kawakita M, Masuda T, et al. 1992. Synergistic effects of interleukin 3 and interleukin 11 on murine megakaryopoiesis in serum-free culture. Exp. Hematol. 20:1011-16
40. Burstein SA, Mei R-L, Henthorn J, et al. 1992. Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J. Cell. Physiol. 153:305-12
41. Williams N. 1991. Is thrombopoietin interleukin 6? Exp. Hematol. 19:714-18
42. Hill RJ, Warren MK, Levin J. et al. 1992. Evidence that interleukin-6 does not play a role in the stimulation of platelet production after induction of acute thrombocytopenia. Blood 80:346-51
43. Straneva JE, van Besien KW, Derigs G, et al. 1992. Is interleukin 6 the physiological regulator of thrombopoiesis? Exp. Hematol. 20:47-50
44. Tsukada J, Misago M, Ogawa R, et al. 1993. Synergism between serum factor(s) and erythropoietin in inducing murine megakaryocyte colony formation: The synergistic factor in serum is distinct from interleukin-11 and stem cell factor (c-kit ligand). Blood 81:866-67
45. Wendling F, Varlet P, Charon M, et al. 1986. A retrovirus complex inducing an acute myeloproliferative leukemia disorder in mice. Virology 149:242-46
46. Souyri M, Vigon I, Penciolelli J-F, et al. 1990. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 63:1137-47
47. Vigon I, Mornon J-P, Cocault L, et al. 1992. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc. Natl. Acad Sci. USA 89: 5640-44
48. Cosman D. 1993. The hematopoietin receptor superfamily. Cytokine 5:95-106
49. Kishimoto T, Taga T, Akira S. 1994. Cytokine signal transduction. Cell 76:253-62
50. Long MW, Heffner CH, Williams JL, et al. 1990. Regulation of megakaryocyte phenotype in human erythroleukemia cells. J. Clin. Invest. 85:1072-84
51. Vigon I, Dreyfus F, Melle J, et al. 1993. Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood 82:877-83
52. Methia N, Louache F, Vainchenker W, et al. 1993. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 82:1395-401
53. Kaushansky K, Lok S, Holly RD, et al. 1994. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369: 568-71
54. Zeigler FC, de Sauvage F, Widmer HR, et al. 1994. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 84:4045-52
55. Wendling F, Maraskovsky E, Debili N, et al. 1994. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369: 571-74
56. Debili N, Wendling F, Katz A, et al. 1995. The Mpl igand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 86:2516-25
57. Kaushansky K, Broudy VC, Lin N, et al. 1995. Thrombopoietin, the Mpl-ligand, is essential for full megakaryocyte development. Proc. Natl. Acad. Sci. USA 92: 3234-38
58. Choi ES, Nichol JL, Hokom MM, et al. 1995. Platelets generated in vitro from pro-platelet-displaying human megakaryocytes are functional. Blood 85:402-13
59. Nichol J, Hokom M, Hornkohl A, et al. 1995. Megakaryocyte growth and development factor: analysis of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy induced thrombocytopenia. J. Clin. Invest. 95: 2973-78
60. Stoffel R, Wiestner A, Skoda R. 1996. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87:567-73
61. Emmons RVB, Reid DM, Cohen RL, et al. 1996. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87:4068-71
62. Taylor K, Pitcher L, Nichol J, et al. 1995. Inappropriate elevation and loss of feedback regulation of thrombopoietin in essential thrombocythaemia. Blood 86(Suppl. 1):49a
63. Kaushansky K, Broudy VC, Grossmann A, et al. 1995. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J. Clin. Invest. 96:1683-87
64. Kobayashi M, Laver JH, Kato T, et al. 1995. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 86:2494-99
65. Ku H, Yonemura Y, Kaushansky K, et al. 1996. Thrombopoietin, the ligand for the Mpl receptor, synergy with steel factor and other early-acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 87:4544-51
66. Sitnicka E, Lin N, Priestley GV, et al. 1996. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 87:4998-5005
67. Broudy VC, Lin NL, Kaushansky K. 1995. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and IL-11 to enhance murine MK colony growth and increases MK ploidy in vitro. Blood 85:1719-26
68. Ikebuchi K, Clark SC, Ihle JN, et al. 1988. Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc. Natl. Acad. Sci. USA 85: 3445-49
69. McDonald TP, Sullivan PS. 1993. Mega karyocytic and erythrocytic cell lines share a common precursor cell. Exp. Hematol. 21:1316-20
70. Hunt P. 1995. A bipotential megakaryocyte/erythrocyte progenitor cell: The link between erythropoiesis and megakaryopoiesis becomes stronger. J. Lab. Clin. Med. 125:303-4
71. Levin J, Levin FC, Hull DF III, et al. 1982. The effects of thrombopoietin on megakaryocyte-CFC, megakaryocytes, and thrombopoiesis: with studies of ploidy and platelet size. Blood 60:989-98
72. Corash L, Chen HY, Levin J, et al. 1987. Regulation of thrombopoiesis: effects of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume. Blood 70:177-85
73. Kuter DJ, Rosenberg RD. 1990. Regulation of megakaryocyte ploidy in vivo in the rat. Blood 75:74-81
74. Alexander WS, Roberts AW, Nicola NA, et al. 1996. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 87:2162-70
75. de Sauvage FJ, Luoh S-M, Carver-Moore K, et al. 1995. Deficiencies in early and late stages of megakaryocytopoiesis in TPO-KO mice. Blood 86:255a
76. Farese AM, Hunt P, Boone T, et al. 1995. Recombinant human megakaryocyte growth and development factor stimulates thrombocytosis in normal nonhuman primates. Blood 86:54-59
77. Sprugel KH, Humes JM, Grossmann A, et al. 1994. Recombinant thrombopoietin stimulates rapid platelet recovery in thrombocytopenic mice. Blood 84(Suppl. 1): 242a
78. Ulich TR, del Castillo J, Yin S, et al. 1995. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 86: 971-76
79. Hokom MM, Lacey D, Kintsler OB, et al. 1995. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carbo platin and irradiation in mice. Blood 86: 4486-92
80. Begley G, Basser R, Clarke K, et al. 1996. Randomized, double-blind, placebo-controlled phase I trial of pegylated megakaryocyte growth and development factor administered to patients with advanced cancer after chemotherapy. Proc. ASCO 15: 271
81. Fannucchi M, Glaspy J, Crawford J, et al. 1996. Safety and biological effects of pegylated megakaryocyte growth and development factor in lung cancer patients receiving carboplatin and paclitaxel: randomized, placebo-controlled phase I study. Proc. ASCO 15:271
82. Vadhan-Raj S, Burris H, Benjamin RS, et al. 1996. Single-dose therapy with recombinant human thrombopoietin (rhTPO) in patients receiving cytotoxic chemotherapy. Proc. ASCO 15:24